Literature DB >> 16438753

Preeclampsia: current understanding of the molecular basis of vascular dysfunction.

Sowndramalingam Sankaralingam1, Ivan A Arenas, Manoj M Lalu, Sandra T Davidge.   

Abstract

Preeclampsia is a pregnancy-specific disorder characterised by hypertension and proteinuria occurring after the 20th week of gestation. Delivery of the placenta results in resolution of the condition, implicating the placenta as a central culprit in the pathogenesis of preeclampsia. In preeclampsia, an inadequate placental trophoblast invasion of the maternal uterine spiral arteries results in poor placental perfusion, leading to placental ischaemia. This could result in release of factors into the maternal circulation that cause widespread activation or dysfunction of the maternal endothelium. Factors in the maternal circulation might induce oxidative stress and/or elicit an inflammatory response in the maternal endothelium, resulting in the altered expression of several genes involved in the regulation of vascular tone. This review addresses the potential circulating factors and the molecular mechanisms involved in the alteration of vascular function that occurs in preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16438753     DOI: 10.1017/S1462399406010465

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  29 in total

1.  17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model.

Authors:  Lorena M Amaral; Denise C Cornelius; Ashlyn Harmon; Janae Moseley; James N Martin; Babbette LaMarca
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Ascorbate prevents placental oxidative stress and enhances birth weight in hypoxic pregnancy in rats.

Authors:  H G Richter; E J Camm; B N Modi; F Naeem; C M Cross; T Cindrova-Davies; O Spasic-Boskovic; C Dunster; I S Mudway; F J Kelly; G J Burton; L Poston; D A Giussani
Journal:  J Physiol       Date:  2012-01-30       Impact factor: 5.182

3.  The mucin MUC16 (CA125) binds to NK cells and monocytes from peripheral blood of women with healthy pregnancy and preeclampsia.

Authors:  Chanel Tyler; Arvinder Kapur; Mildred Felder; Jennifer A Belisle; Christine Trautman; Jennifer A A Gubbels; Joseph P Connor; Manish S Patankar
Journal:  Am J Reprod Immunol       Date:  2012-03-01       Impact factor: 3.886

4.  Increased expression of matrix metalloproteinase-1 in systemic vessels of preeclamptic women: a critical mediator of vascular dysfunction.

Authors:  Guadalupe Estrada-Gutierrez; Renato E Cappello; Nikita Mishra; Roberto Romero; Jerome F Strauss; Scott W Walsh
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

5.  Serelaxin improves the pathophysiology of placental ischemia in the reduced uterine perfusion pressure rat model of preeclampsia.

Authors:  Jose A Santiago-Font; Lorena M Amaral; Jessica Faulkner; Tarek Ibrahim; Venkata Ramana Vaka; Mark W Cunningham; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-09-14       Impact factor: 3.619

6.  Progesterone supplementation attenuates hypertension and the autoantibody to the angiotensin II type I receptor in response to elevated interleukin-6 during pregnancy.

Authors:  Lorena M Amaral; Luissa Kiprono; Denise C Cornelius; Carrie Shoemaker; Kedra Wallace; Janae Moseley; Gerd Wallukat; James N Martin; Ralf Dechend; Babbette LaMarca
Journal:  Am J Obstet Gynecol       Date:  2014-02-15       Impact factor: 8.661

Review 7.  Matrix metalloproteinases as drug targets in preeclampsia.

Authors:  Ana C T Palei; Joey P Granger; Jose E Tanus-Santos
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

Review 8.  Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature.

Authors:  A K Chow; J Cena; R Schulz
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

9.  Separation and Determination of Fatty Acids from Lipid Fractions by High-Performance Liquid Chromatography: Cholesterol Esters of Umbilical Cord Arteries.

Authors:  Lech Romanowicz; Stefan Jaworski; Zofia Galewska; Tomasz Gogiel
Journal:  Toxicol Mech Methods       Date:  2008-06-23       Impact factor: 2.987

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.